Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy. However, a s...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley
2025-08-01
|
| Sarja: | Annals of Clinical and Translational Neurology |
| Aiheet: | |
| Linkit: | https://doi.org/10.1002/acn3.70095 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|